A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.

Davis-Gardner ME, Weber JA, Xie J, Pekrun K, Alexander EA, Weisgrau KL, Furlott JR, Rakasz EG, Kay MA, Gao G, Farzan M, Gardner MR

Open source

DOI: 10.3389/fimmu.2023.1105617
Published: 2023
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1105617,
  title = {A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.},
  author = {Davis-Gardner ME and Weber JA and Xie J and Pekrun K and Alexander EA and Weisgrau KL and Furlott JR and Rakasz EG and Kay MA and Gao G and Farzan M and Gardner MR},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1105617},
  url = {https://doi.org/10.3389/fimmu.2023.1105617}
}

RIS

TY  - JOUR
TI  - A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.
AU  - Davis-Gardner ME
AU  - Weber JA
AU  - Xie J
AU  - Pekrun K
AU  - Alexander EA
AU  - Weisgrau KL
AU  - Furlott JR
AU  - Rakasz EG
AU  - Kay MA
AU  - Gao G
AU  - Farzan M
AU  - Gardner MR
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1105617
UR  - https://doi.org/10.3389/fimmu.2023.1105617
ER  -

APA

ME, D., JA, W., J, X., K, P., EA, A., KL, W., JR, F., EG, R., MA, K., G, G., M, F., & MR, G. (2023). A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1105617

Source records

pubmed · retrieved 2026-09-25T18:18:38.002Z